Professor Department of Pharmacology & Therapeutics. McGill University
Molecular Basis of Mitochondrial Quality Control in Parkinson’s Disease: a Combined Structural and Proteomics Approach
Mutations in Parkin and PINK1 cause an early-onset autosomal recessive form of Parkinson’s disease (PD). PINK1 is a mitochondrial kinase that builds upon damaged mitochondria and recruits Parkin to induce the selective degradation of damaged mitochondrial proteins. Using a combination of bottom-up and intact protein mass spectrometry, as well as NMR spectroscopy and X-ray crystallography, I will describe the mechanism of PINK1 activation through autophosphorylation, as well as the sequence of phosphorylation events that triggers Parkin’s E3 ligase activation on mitochondria.
Jean-François Trempe is assistant professor at the department of Pharmacology at McGill University since 2013. He obtained a D.Phil. in Biochemistry at the University of Oxford and then perused his postdoctoral studies at McGill University and at the Montreal Neurological Institute. His group research activities are centered on the structure and function of proteins implicated in Parkinson’s disease, mainly Parkin and PINK1 that mediate neuroprotection and mitochondrial maintenance. In addition to our work on the composition and 3D structure of molecular complexes formed by Parkin and PINK1 on mitochondria, our research activities also involve the development of novel therapies for Parkinson disease. Our group use a broad range of structural biology tools including X-ray crystallography, NMR spectroscopy, SAXS, electron microscopy and mass spectrometry. These tools provide us valuable information on how enzymes become active and modify their substrates, and provide us valuable insight into the development of novel pharmacological targets.
Date(s) - April 16, 2019
6:00 pm - 9:00 pm
Emplacement / Location
Morris and Rosalind Goodman Agora